FDA Approves First Monoclonal Antibody Biosimilar
The FDA approved Celltrion’s Inflectra™ (biosimilar infliximab) across all eligible indications of the reference product, Janssen Biotech’s...
VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy
VBL Therapeutics won an ILS8.75 (approximately $2.5 million) grant from the Israel Innovation Authority to support continued clinical...
MRSA Vaccine Draws Closer to Reality
Scientists say both LUK-PV and LUK-ED are leukotoxins that target and poison the white blood cells meant to fight the bacterial infection, but...
FDA Lifts Holds on Epizyme Cancer Candidate, Sarepta DMD Gene Therapy
The FDA has lifted a partial clinical hold imposed in April on Epizyme’s cancer treatment tazemetostat, as well as the clinical hold carried out...
Peptide Nucleic Acids Used to Edit Genes, Cure Mice of Inherited Blood Disorder
In gene editing, the kindest cut may be no cut at all. This possibility was explored by researchers working with peptide nucleic acids (PNAs),...
High Dose AAV Vector Experiments Prove Extremely Toxic in Animal Studies
Gene Therapy Innovator Dr. James Wilson Raises Serious Concerns in New Report
Gene therapy pioneer James M. Wilson, M.D., Ph.D., and colleagues...
Humanizing Animals for Immuno-Oncology
Success in Humanizing Mice Has Inspired Similar Efforts in Rats, Pigs, and Other Animals
Ian Clift, Ph.D.
One of the major roadblocks to curing...



